Sterile Compounding Basics for Pharmacy Technicians (USP 797)

Introduction to Sterile Compounding

Sterile compounding is one of the most critical and specialized skills a pharmacy technician can develop. It involves preparing medications that will be administered directly into the body, such as intravenous (IV) solutions, injections, and ophthalmic preparations. Because these preparations bypass the body's natural defenses, they must be absolutely free of microbial contamination and particulate matter.

The United States Pharmacopeia (USP) Chapter 797 establishes the standards for sterile compounding in pharmacy settings. Understanding these standards is essential for pharmacy technicians who work in hospital pharmacies, infusion centers, and compounding pharmacies, and this topic also appears on the PTCE.

Why Sterile Compounding Matters

Contaminated sterile preparations can cause severe patient harm, including bloodstream infections, sepsis, and even death. Several high-profile contamination incidents have highlighted the importance of strict sterile compounding standards. The 2012 New England Compounding Center outbreak, which caused fungal meningitis in hundreds of patients and resulted in over 60 deaths, led to sweeping regulatory changes in compounding pharmacy oversight.

As a pharmacy technician involved in sterile compounding, you are directly responsible for protecting patient safety through proper technique and adherence to established protocols.

USP 797 Standards

USP 797 is the chapter that governs pharmaceutical compounding of sterile preparations. It establishes requirements for personnel training, facilities, environmental monitoring, and quality assurance.

Risk Level Categories

USP 797 categorizes compounded sterile preparations (CSPs) based on contamination risk:

Category 1 (Low Risk) - Preparations compounded under conditions that minimize the chance of contamination, with shorter beyond-use dates. Examples include simple transfers from commercially available vials to IV bags using closed-system transfer methods.
Category 2 (Higher Risk) - Preparations that require more complex manipulation, longer storage, or are prepared from non-sterile starting ingredients. These require additional quality controls and testing.

The Clean Room Environment

Sterile compounding must be performed in a controlled environment designed to minimize contamination. The clean room consists of several zones with progressively cleaner air quality.

Primary Engineering Controls (PECs)

The PEC is the device that provides the first-air environment for compounding. The two main types are:

Laminar Airflow Workbench (LAFW) - Provides horizontal or vertical HEPA-filtered air over the work surface. Used for non-hazardous sterile compounding.
Biological Safety Cabinet (BSC) - Provides HEPA-filtered air and contains hazardous aerosols within the cabinet. Required for compounding hazardous drugs such as chemotherapy agents.
Compounding Aseptic Isolator (CAI) - An enclosed, HEPA-filtered workspace that provides isolation from the surrounding environment.

Secondary Engineering Controls (SECs)

The SEC is the room that houses the PEC. It must meet specific air quality requirements:

The buffer area (clean room) should maintain ISO Class 7 air quality or better
The ante area provides a transition space between the general environment and the buffer area
Positive pressure differentials prevent unfiltered air from entering the clean room
Temperature should be maintained at 68 degrees Fahrenheit or cooler to discourage microbial growth and for personnel comfort in gowning

Aseptic Technique

Aseptic technique refers to the practices and procedures used to prevent contamination during sterile compounding. Mastering aseptic technique is fundamental for every pharmacy technician who works in a clean room.

Hand Hygiene

Proper hand washing is the first and most important step in aseptic technique. Before entering the clean room, wash your hands and forearms thoroughly with antimicrobial soap for at least 30 seconds. Scrub between fingers, around nails, and up to the elbows. Dry with lint-free towels.

Garbing Procedures

Proper garbing prevents personnel from introducing contaminants into the clean room. The standard garbing sequence includes:

Remove all jewelry, cosmetics, and personal items
Don shoe covers (one at a time, stepping over the line of demarcation)
Put on a hair cover, ensuring all hair is contained
Put on a face mask, covering both the nose and mouth
Perform hand hygiene
Don a sterile gown
Apply sterile, powder-free gloves
Sanitize gloves with sterile 70% isopropyl alcohol (IPA)

Working in the LAFW

When compounding in a laminar airflow workbench, follow these critical principles:

Allow the LAFW to run for at least 30 minutes before use to establish proper airflow
Clean all surfaces with sterile 70% IPA before beginning work
Never block first air (the direct path of HEPA-filtered air) from reaching critical sites
Work at least 6 inches inside the outer edge of the LAFW
Never place items between the HEPA filter and the critical site
Swab all vial tops and injection ports with 70% IPA and allow them to dry before use
Never touch critical sites (needle tips, syringe tips, vial tops after swabbing, IV port openings)

Beyond-Use Dating

Beyond-use dates (BUDs) specify the maximum time a compounded preparation can be stored and still be considered safe and effective. USP 797 establishes default BUDs based on the category of the preparation and the storage conditions.

Factors that affect beyond-use dating include:

The risk category of the preparation
Storage temperature (room temperature, refrigerated, or frozen)
Whether the preparation has been tested for sterility
The chemical stability of the drug in the compounded formulation

Always follow your pharmacy's specific BUD policies, which must comply with USP 797 standards.

Quality Assurance in Sterile Compounding

Quality assurance measures ensure that compounded preparations are consistently safe and effective:

Media fill testing - Technicians must pass media fill tests (also called process validation) to demonstrate their ability to compound without introducing contamination. This involves compounding with growth media instead of actual drugs and incubating the samples to check for microbial growth.
Environmental monitoring - Regular testing of air quality and surface contamination in the clean room
Visual inspection - Every compounded preparation must be visually inspected for particulate matter, discoloration, and container integrity before dispensing
Documentation - Complete records of each compounded preparation, including ingredients, quantities, dates, and the compounder's identity

PTCE Exam Tips for Sterile Compounding

Sterile compounding questions on the PTCE may cover:

Proper garbing order and hand hygiene procedures
ISO classification levels for clean room areas
Principles of aseptic technique in the LAFW
Beyond-use dating categories
Hazardous drug handling requirements
The purpose and types of primary engineering controls

Sterile compounding demands precision, discipline, and a genuine commitment to patient safety. Whether you are preparing a simple IV antibiotic or a complex total parenteral nutrition solution, every step matters. Mastering these fundamentals positions you for success on the PTCE and opens doors to specialized, higher-paying pharmacy technician roles.